4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-23-001137
SVP and General Counsel sold 13,000 shares at an average $282.92 ($3,677,977)
- SVP and General Counsel acquired 13,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Option exercise | +13,000 | $91.79 | $1,193,270 | 13,000 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −600 | $277.91 | $166,746 | 12,400 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −400 | $279.10 | $111,640 | 12,000 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −1,800 | $280.66 | $505,188 | 10,200 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −2,656 | $281.97 | $748,912 | 7,544 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −2,628 | $282.97 | $743,645 | 4,916 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −1,549 | $283.85 | $439,684 | 3,367 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −829 | $285.15 | $236,389 | 2,538 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −2,038 | $285.74 | $582,338 | 500 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −400 | $286.62 | $114,648 | 100 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Sale | −100 | $287.86 | $28,786 | 0 | D |
| Derivatives | |||||||
| Lynch Brian Joseph SVP and General Counsel | 2023-01-03 | Option exercise · Stock Option (Right to Buy) | −13,000 | 12,000 | D | ||
| Open-market sales · 13,000 sh · avg $282.92 · $3,677,977 | |||||||
Loading xslF345X03/doc4.xml…